Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: A five-year follow-up study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Lin, Yu Cheng ^a,b,c   Chen, Jong Dar ^d   Lo, Su Huey ^a   Chen, Pau Chung ^b  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; FORECASTING; HUMAN; MALE; MASS SCREENING; METABOLIC SYNDROME X; METHODOLOGY; OCCUPATIONAL HEALTH; PROGNOSIS; RISK; TAIWAN;

ADULT; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; OCCUPATIONAL HEALTH; ODDS RATIO; PROGNOSIS; RISK; TAIWAN;

EID: 78649530808     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-747     Document Type: Article

References (40)

1. Independent and combined influence of physical activity and perceived stress on the metabolic syndrome in male law enforcement officers. HL Yoo JC Eisenmann WD Franke, J Occup Environ Med 2009 51 46 53 10.1097/JOM. 0b013e31817f9e43 19136873
2. Occupation-related differences in the prevalence of metabolic syndrome. MA Sanchez-Chaparro E Calvo-Bonacho A Gonzalez-Quintela C Fernandez-Labandera M Cabrera JC Sainz A Fernandez-Meseguer JR Banegas LM Ruilope P Valdivielso J Roman-Garcia, Diabetes Care 2008 31 1884 1885 10.2337/dc08-0431 18753667
3. Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample. C Oberlinner PM Humpert PP Nawroth A Zober M Morcos, Acta Diabetol 2008 45 31 35 10.1007/s00592-007-0015-6 17882349
4. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. VG Athyros EN Liberopoulos DP Mikhailidis AA Papageorgiou ES Ganotakis K Tziomalos AI Kakafika A Karagiannis S Lambropoulos M Elisaf, Angiology 2007 58 689 697 10.1177/0003319707306146 18216378
5. Leisure-time physical activity is associated with a reduced risk for metabolic syndrome. ER Cho A Shin J Kim SH Jee J Sung, Ann Epidemiol 2009 19 784 792 10.1016/j.annepidem.2009.06.010 19825459
6. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. BM Cheung NM Wat S Tam GN Thomas GM Leung CH Cheng J Woo ED Janus CP Lau TH Lam KS Lam, Clin Endocrinol (Oxf) 2008 68 730 737 10.1111/j.1365-2265.2007.03110.x 17980012
7. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Y Mori K Hoshino K Yokota T Yokose N Tajima, Exp Clin Endocrinol Diabetes 2005 113 334 339 10.1055/s-2005-865680 15977101
8. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. S Strauss E Gavish P Gottlieb L Katsnelson, AJR Am J Roentgenol 2007 189 320 323 10.2214/AJR.07.2123 18029843
9. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). P Mishra ZM Younossi, Am J Gastroenterol 2007 102 2716 2717 10.1111/j.1572-0241.2007.01520.x 18042105
10. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. A Alkerwi M Boutsen M Vaillant J Barre ML Lair A Albert M Guillaume M Dramaix, Atherosclerosis 2009 204 624 635 10.1016/j.atherosclerosis.2008.10.036 19084839
11. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study. PF Hsu SY Chuang HM Cheng ST Tsai P Chou CH Chen, Diabetes Res Clin Pract 2008 79 461 467 10.1016/j.diabres.2007.09.021 18006171
12. Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year follow-up. YC Lin TJ Hsiao PC Chen, Chronobiol Int 2009 26 740 755 10.1080/07420520902929029 19444753
13. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women. MJ Vanhala EA Kumpusalo TK Pitkajarvi IL Notkola JK Takala, J Hypertens 1997 15 475 481 10.1097/00004872-199715050-00002 9169999
14. Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study. EJ Feskens D Kromhout, Arterioscler Thromb 1994 14 1641 1647 7918315
15. A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase. PH Chen JD Chen YC Lin, World J Gastroenterol 2009 15 5598 5603 10.3748/wjg.15.5598 19938201
16. Sonographic fatty liver, overweight and ischemic heart disease. YC Lin HM Lo JD Chen, World J Gastroenterol 2005 11 4838 4842 16097054
17. A SAS program calculating three measures of interaction with confidence intervals. M Lundberg P Fredlund J Hallqvist F Diderichsen, Epidemiology 1996 7 655 656 8899400
18. Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study. BJ Kim BS Kim KC Sung JH Kang MH Lee JR Park, Diabetes Care 2009 32 1314 1316 10.2337/dc09-0060 19389815
19. Impact of a worksite intervention program on cardiovascular risk factors: a demonstration project in an Indian industrial population. D Prabhakaran P Jeemon S Goenka R Lakshmy KR Thankappan F Ahmed PP Joshi BV Mohan R Meera MS Das, et al. J Am Coll Cardiol 2009 53 1718 1728 10.1016/j.jacc.2008.12.062 19406349
20. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. MW Knuiman J Hung ML Divitini TM Davis JP Beilby, Eur J Cardiovasc Prev Rehabil 2009 16 235 241 10.1097/HJR.0b013e32832955fc 19238082
21. The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up. D Martins N Tareen G Ogedegbe D Pan K Norris, J Natl Med Assoc 2008 100 565 571 18507210
22. Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome. FM Adam MG Nara JM Adam, Acta Med Indones 2006 38 179 184 17132879
23. The association between changes in metabolic syndrome and changes in cost in a workplace population. AB Schultz DW Edington, J Occup Environ Med 2009 51 771 779 10.1097/JOM.0b013e3181a88da5 19528830
24. A model for the dynamics of human weight cycling. A Goldbeter, J Biosci 2006 31 129 136 10.1007/BF02705242 16595882
25. Obesity, physical activity and the development of metabolic syndrome: the Atherosclerosis Risk in Communities study. P Cheriyath Y Duan Z Qian L Nambiar D Liao, Eur J Cardiovasc Prev Rehabil 2010 17 309 313 20300002
26. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. CH Saely A Vonbank P Rein M Woess S Beer S Aczel V Jankovic C Boehnel L Risch H Drexel, Clin Chim Acta 2008 397 82 86 10.1016/j.cca.2008.07. 024 18708042
27. Hyperinsulinemia and insulin resistance related metabolic syndrome. JH Sun LC See WC Hsu JS Tsai JD Lin, Chang Gung Med J 2001 24 11 18 11299972
28. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. CH Kim ZM Younossi, Cleve Clin J Med 2008 75 721 728 10.3949/ccjm.75.10.721 18939388
29. Metabolic syndrome in a family practice population: prevalence and clinical characteristics. C van den Hooven J Ploemacher M Godwin, Can Fam Physician 2006 52 982 983 17273503
30. MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4-L5 level. G Valsamakis A Jones R Chetty PG McTernan A Boutsiadis AH Barnett AK Banerjee S Kumar, Curr Med Res Opin 2008 24 1853 1860 10.1185/03007990802185757 18507894
31. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. A Xu AW Tso BM Cheung Y Wang NM Wat CH Fong DC Yeung ED Janus PC Sham KS Lam, Circulation 2007 115 1537 1543 10.1161/CIRCULATIONAHA.106.647503 17389279
32. What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects? S Bo R Rosato G Ciccone R Gambino M Durazzo L Gentile M Cassader P Cavallo-Perin G Pagano, Diabetes Metab Res Rev 2009 25 76 82 10.1002/dmrr.910 19145586
33. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. P Holvoet DH Lee M Steffes M Gross DR Jacobs Jr, JAMA 2008 299 2287 2293 10.1001/jama.299.19.2287 18492970
34. Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. C Irace C Cortese E Fiaschi C Carallo G Sesti E Farinaro A Gnasso, Hypertension 2005 45 597 601 10.1161/01.HYP.0000158945.52283. c2 15738347
35. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. H Tomiyama H Hashimoto Y Hirayama M Yambe J Yamada Y Koji K Shiina Y Yamamoto A Yamashina, Hypertension 2006 47 180 188 10.1161/01.HYP.0000198539.34501.1a 16380535
36. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality - results of prospective analysis for the Atherosclerosis Risk in Communities study. Y Hong X Jin J Mo HM Lin Y Duan M Pu DL Wolbrette D Liao, J Intern Med 2007 262 113 122 10.1111/j.1365-2796.2007. 01781.x 17598819
37. Intervention with education and exercise reverses the metabolic syndrome in adults. V Mujica A Urzua E Leiva N Diaz R Moore-Carrasco M Vasquez E Rojas G Icaza C Toro R Orrego I Palomo, J Am Soc Hypertens 2010 4 148 153 10.1016/j.jash.2010.02.008 20471000
38. Treatment of hypertension in metabolic syndrome: implications of recent clinical trials. AN Makaryus P Akhrass SI McFarlane, Curr Diab Rep 2009 9 229 237 10.1007/s11892-009-0037-2 19490825
39. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. VG Athyros AI Kakafika AA Papageorgiou KI Paraskevas K Tziomalos P Anagnostis E Pagourelias C Koumaras A Karagiannis DP Mikhailidis, Curr Med Res Opin 2008 24 1593 1599 10.1185/03007990802069563 18430270
40. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. JD Lundgren R Malcolm M Binks PM O'Neil, Int J Obes (Lond) 2009 33 144 150 10.1038/ijo.2008.225 19015662